More about

Progestin

News
June 03, 2024
3 min read
Save

Hormonal contraceptive gel for men suppresses sperm production by week 8

BOSTON — In a phase 2b trial, a hormonal contraceptive gel for use by men worked faster than expected, suppressing sperm count to effective levels by week 8 of use, making it an “attractive” product, according to a speaker at ENDO 2024.

News
October 02, 2023
2 min read
Save

Higher endometrial cancer, hyperplasia rates with conjugated estrogens/bazedoxifene

In the first years of use, women prescribed conjugated estrogens/bazedoxifene vs. estrogen/progestin for menopausal symptoms may have higher rates of endometrial cancer and endometrial hyperplasia but lower breast cancer rates.

News
September 30, 2023
2 min read
Save

Menopausal hormone therapy prescriptions remain low in US

PHILADELPHIA — The number of women aged at least 50 years prescribed hormone therapy for menopause symptoms remains low, particularly for Hispanic women, despite good efficacy and safety, according to a presenter.

News
July 05, 2023
2 min read
Save

Use of progestin therapy increasing for endometrial intraepithelial neoplasia

For premenopausal women with endometrial intraepithelial neoplasia, use of conservative treatment with progestin increased and hysterectomy declined from 2008 to 2020, researchers reported.

News
December 21, 2022
7 min watch
Save

VIDEO: FDA poised to withdraw preterm birth drug from market

The FDA “appears poised” to withdraw the only drug indicated for the prevention of preterm birth from the market following a recent recommendation to do so.

News
December 08, 2022
3 min read
Save

Q&A: Survey supports OTC progestin-only pill availability to increase contraceptive access

Over-the-counter progestin-only pills may provide the benefits of other contraceptives while eliminating substantial barriers to access, according to a survey of participants in a study of OTC progestin-only pills.

News
October 19, 2022
1 min read
Save

FDA advisers recommend withdrawing preterm birth drug from market

The FDA Obstetrics, Reproductive and Urologic Drugs Advisory Committee voted 14-1 to remove a drug indicated for preventing preterm birth from the market due to lack of effectiveness.

News
September 15, 2022
2 min read
Save

Certain contraceptives may increase risk for thrombotic events in women with obesity

Use of combined oral contraceptives in women with obesity may confer elevated CV risk in the form of venous and arterial thromboembolism, researchers reported.

News
April 08, 2022
7 min read
Save

20 years of data lead to changes in perceptions, usage of menopausal HT

During the past 2 decades, Endocrine Today has reported on the latest developments in hormone therapy for symptoms associated with menopause. For its 20th year, the publication is taking a look back.

News
January 21, 2020
2 min read
Save

Use of intrauterine devices may decrease risk for ovarian cancer

About 14,000 women each year die of ovarian cancer, making it one of the deadliest gynecologic cancers.

View more